Ventyx‑Eli Lilly Merger: Insider Sales, Strategic Growth & Market Access Impact
Insider sales at the Ventyx‑Eli Lilly merger reveal confidence in $14.00 per‑share value, while the deal expands access to oncology and rare‑disease drugs, boosting market‑access, competitive positioning and drug‑development feasibility for the comb…
4 minutes to read